10-K/A

BIOTIME, INC 10-KA 12-31-2012

Company: Lineage Cell Therapeutics, Inc.
Filed: April 30, 2013
Period of Report: December 31, 2012
Accession Number: 0001140361-13-017969

View Document ↗ View on SEC.gov ↗